









Mercado
/
Acciones
/
nasdaq-zts
/

Zoetis Inc

ZTS

147.380USD

+1.590+1.09%

Cierre 08/01, 16:00（ET）Cotizaciones retrasadas 15 min

65.74BCap. mercado

26.11P/E TTM



Zoetis Inc

147.380

+1.590+1.09%

Descripción general Compañía Finanzas

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Información de la empresa

Símbolo de cotizaciónZTS

Nombre de la empresaZoetis Inc

Fecha de salida a bolsaFeb 01, 2013

Fundada en2012

Director ejecutivoMs. Kristin C. Peck

Número de empleados13800

Tipo de seguridadOrdinary Share

Fin del año fiscalFeb 01

Dirección10 Sylvan Way

CiudadPARSIPPANY

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal07054

Teléfono19738227000

Sitio Webhttps://www.zoetis.com/

Símbolo de cotizaciónZTS

Fecha de salida a bolsaFeb 01, 2013

Fundada en2012

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Kristin C. Peck

Chief Executive Officer, Director

95.01K

+0.02%

Mr. Michael B. Mccallister

Non-Executive Independent Chairman of the Board

25.86K

-6.61%

Mr. Gregory (Greg) Norden

Independent Director

16.95K

+12.20%

Ms. Louise M. Parent

Independent Director

15.26K

Mr. Frank A. D'amelio

Independent Director

14.81K

Mr. Sanjay Khosla

Independent Director

9.81K

Mr. Robert J. Polzer, Ph.D.

Executive Vice President, President - Research and Development

6.19K

+0.39%

Ms. Rimma Driscoll

Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices

5.19K

+8.28%

Ms. Vanessa Broadhurst

Independent Director

2.82K

+51.75%

Mr. Jamie Brannan

Executive Vice President, Chief Commercial Officer

2.59K

+19.25%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Kristin C. Peck

Chief Executive Officer, Director

95.01K

+0.02%

Mr. Michael B. Mccallister

Non-Executive Independent Chairman of the Board

25.86K

-6.61%

Mr. Gregory (Greg) Norden

Independent Director

16.95K

+12.20%

Ms. Louise M. Parent

Independent Director

15.26K

Mr. Frank A. D'amelio

Independent Director

14.81K

Mr. Sanjay Khosla

Independent Director

9.81K

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Parasiticides

562.00M

25.32%

Vaccines

447.00M

20.14%

Dermatology

390.00M

17.57%

Anti-infectives

249.00M

11.22%

Pain and sedation

210.00M

9.46%

Other

362.00M

16.31%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

1.18B

53.29%

Other emerging markets

248.00M

11.17%

Other Developed

133.00M

5.99%

Brazil

88.00M

3.96%

United Kingdom

77.00M

3.47%

Other

491.00M

22.12%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Parasiticides

562.00M

25.32%

Vaccines

447.00M

20.14%

Dermatology

390.00M

17.57%

Anti-infectives

249.00M

11.22%

Pain and sedation

210.00M

9.46%

Other

362.00M

16.31%

Estadísticas de accionistas

Actualizado: vie., 21 de feb

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.29%

BlackRock Institutional Trust Company, N.A.

5.20%

State Street Global Advisors (US)

4.45%

State Farm Insurance Companies

3.79%

Geode Capital Management, L.L.C.

2.47%

Other

74.80%

Accionistas

Proporción

The Vanguard Group, Inc.

9.29%

BlackRock Institutional Trust Company, N.A.

5.20%

State Street Global Advisors (US)

4.45%

State Farm Insurance Companies

3.79%

Geode Capital Management, L.L.C.

2.47%

Other

74.80%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

47.98%

Investment Advisor/Hedge Fund

32.14%

Research Firm

4.83%

Insurance Company

3.89%

Bank and Trust

2.67%

Pension Fund

2.51%

Sovereign Wealth Fund

1.21%

Hedge Fund

1.20%

Family Office

0.14%

Other

3.42%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

3264

431.39M

96.89%

-5.29M

2025Q1

3284

432.42M

97.12%

-4.21M

2024Q4

3199

430.60M

96.14%

-9.58M

2024Q3

3090

434.14M

95.81%

-13.19M

2024Q2

3062

437.75M

95.94%

-9.33M

2024Q1

3060

439.45M

96.16%

-2.63M

2023Q4

3074

438.13M

95.43%

-2.08M

2023Q3

2966

434.04M

94.28%

-3.00M

2023Q2

2949

430.67M

93.19%

-11.77M

2023Q1

2913

436.42M

94.33%

-5.14M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

41.36M

9.29%

+189.52K

+0.46%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

23.15M

5.2%

+208.71K

+0.91%

Mar 31, 2025

State Street Global Advisors (US)

19.80M

4.45%

-46.05K

-0.23%

Mar 31, 2025

State Farm Insurance Companies

16.88M

3.79%

-120.91K

-0.71%

Mar 31, 2025

Geode Capital Management, L.L.C.

10.99M

2.47%

+368.11K

+3.47%

Mar 31, 2025

AllianceBernstein L.P.

10.86M

2.44%

-952.97K

-8.07%

Mar 31, 2025

Polen Capital Management, LLC

8.80M

1.98%

+1.31M

+17.55%

Mar 31, 2025

Wellington Management Company, LLP

6.07M

1.36%

-893.17K

-12.84%

Mar 31, 2025

Wells Fargo Advisors

6.01M

1.35%

+338.64K

+5.97%

Mar 31, 2025

BlackRock Asset Management Ireland Limited

5.36M

1.2%

+511.23K

+10.54%

Mar 31, 2025

ETFs relacionados

Actualizado: dom., 6 de jul

Nombre

Proporción

ProShares Pet Care ETF

10%

VanEck Agribusiness ETF

7.86%

VanEck Pharmaceutical ETF

4.91%

Honeytree US Equity ETF

4.41%

iShares U.S. Pharmaceuticals ETF

4.29%

First Trust NASDAQ Pharmaceuticals ETF

4.08%

SPDR S&P Pharmaceuticals ETF

3.95%

Natixis Vaughan Nelson Select ETF

3.88%

AAM Sawgrass US Large Cap Quality Growth ETF

2.51%

Jensen Quality Growth ETF

2.44%

ProShares Pet Care ETF

Proporción10%

VanEck Agribusiness ETF

Proporción7.86%

VanEck Pharmaceutical ETF

Proporción4.91%

Honeytree US Equity ETF

Proporción4.41%

iShares U.S. Pharmaceuticals ETF

Proporción4.29%

First Trust NASDAQ Pharmaceuticals ETF

Proporción4.08%

SPDR S&P Pharmaceuticals ETF

Proporción3.95%

Natixis Vaughan Nelson Select ETF

Proporción3.88%

AAM Sawgrass US Large Cap Quality Growth ETF

Proporción2.51%

Jensen Quality Growth ETF

Proporción2.44%

Dividendos

Un total de 2.94B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Dec 12, 2024

ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025

Jan 21, 2025

Mar 04, 2025

Jan 21, 2025

Oct 10, 2024

ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024

Oct 31, 2024

Dec 03, 2024

Oct 31, 2024

May 22, 2024

ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024

Jul 18, 2024

Sep 04, 2024

Jul 18, 2024

Feb 06, 2024

ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024

Apr 19, 2024

Jun 04, 2024

Apr 18, 2024

Dec 07, 2023

ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024

Jan 19, 2024

Mar 01, 2024

Jan 18, 2024

Oct 12, 2023

ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023

Nov 01, 2023

Dec 01, 2023

Oct 31, 2023

May 11, 2023

ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023

Jul 21, 2023

Sep 01, 2023

Jul 20, 2023

Feb 08, 2023

ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023

Apr 21, 2023

Jun 01, 2023

Apr 20, 2023

Dec 08, 2022

ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023

Jan 20, 2023

Mar 01, 2023

Jan 19, 2023

Oct 13, 2022

ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022

Nov 01, 2022

Dec 01, 2022

Oct 31, 2022

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

